Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorBusiness Services
Current SymbolNASDAQ:CDLX
Previous Symbol
CUSIPN/A
Phone888-798-5802
Debt
Debt-to-Equity Ratio0.91
Current Ratio3.04
Quick Ratio3.04
Price-To-Earnings
Trailing P/E Ratio-1.61
Forward P/E Ratio-5.90
P/E GrowthN/A
Sales & Book Value
Annual Sales$130.37 million
Price / Sales1.91
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)($8.02)
Net Income$-19,640,000.00
Net Margins-32.03%
Return on EquityN/A
Return on Assets-25.60%
Miscellaneous
Employees342
Outstanding Shares20,260,000
Market Cap$274.17 million
OptionableNot Optionable
Cardlytics (NASDAQ:CDLX) Frequently Asked Questions
What is Cardlytics' stock symbol?
Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."
How were Cardlytics' earnings last quarter?
Cardlytics Inc (NASDAQ:CDLX) issued its quarterly earnings results on Tuesday, November, 13th. The company reported ($0.15) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.63) by $0.48. The business had revenue of $34.58 million for the quarter, compared to analysts' expectations of $37.62 million. The business's revenue for the quarter was up 10.1% compared to the same quarter last year. View Cardlytics' Earnings History.
When is Cardlytics' next earnings date?
What guidance has Cardlytics issued on next quarter's earnings?
Cardlytics updated its FY 2018 earnings guidance on Tuesday, November, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $146-148 million, compared to the consensus revenue estimate of $154.43 million.Cardlytics also updated its Q4 2018 guidance to EPS.
What price target have analysts set for CDLX?
8 brokerages have issued 12-month price targets for Cardlytics' stock. Their forecasts range from $20.00 to $28.00. On average, they anticipate Cardlytics' share price to reach $24.2857 in the next year. This suggests a possible upside of 88.0% from the stock's current price. View Analyst Price Targets for Cardlytics.
What is the consensus analysts' recommendation for Cardlytics?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cardlytics.
What are Wall Street analysts saying about Cardlytics stock?
Here are some recent quotes from research analysts about Cardlytics stock:
- 1. According to Zacks Investment Research, "Cardlytics, Inc. is engaged in developing a purchase intelligence platform. The purchase data includes debit, credit and bill pay data from online and in-store transactions. It helps the marketers identify, reach and influence likely buyers at scale, and measure the impact of marketing spends. The Company also operates an advertising channel, Cardlytics Direct. Cardlytics Direct delivers tailored marketing for marketers and financial institutions. Cardlytics, Inc. is based in ATLANTA, United States. " (11/19/2018)
- 2. SunTrust Banks, Inc. analysts commented, "We hosted CDLX mgt for an NDR this week, during which mgt provided more color around the state of the business following 2Q earnings on 8/14, and progress on the all-important JPM Fargo relationships. As a digital ad channel designed to be bot and fraud proof with attractive ROI, CDLX is gaining enough scale with users and becoming a more relevant platform for advertisers, in our view. The focus now is on-boarding these two new partners while aggressively expanding the sales force to sell the growing ad inventory. We remain positive on CDLX and see ample opportunity for growth. Becoming The Industry Consolidator." (9/11/2018)
Has Cardlytics been receiving favorable news coverage?
Press coverage about CDLX stock has been trending somewhat positive recently, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cardlytics earned a daily sentiment score of 1.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.
Who are some of Cardlytics' key competitors?
Some companies that are related to Cardlytics include Internet Initiative Japan (IIJI), 21Vianet Group (VNET), TrueCar (TRUE), HealthStream (HSTM), Aurora Mobile (JG), Jianpu Technology (JT), Model N (MODN), Pintec Technology (PT), The Rubicon Project (RUBI), Internap (INAP), Sify Technologies (SIFY), Synacor (SYNC), Autoweb (AUTO), GigaMedia (GIGM) and Chinanet Online (CNET).
Who are Cardlytics' key executives?
Cardlytics' management team includes the folowing people:
- Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 55)
- Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 48)
- Mr. David Evans, CFO & Head of Corp. Devel.
- Mr. Sathish Gaddipati, Chief Technology Officer (Age 51)
- Mr. Kirk L. Somers, Chief Legal & Privacy Officer (Age 53)
When did Cardlytics IPO?
(CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.
Who are Cardlytics' major shareholders?
Cardlytics' stock is owned by a variety of of institutional and retail investors. Top institutional investors include FMR LLC (15.77%), Jennison Associates LLC (3.94%), Frontier Capital Management Co. LLC (3.51%), BlackRock Inc. (2.08%), Vanguard Group Inc. (2.00%) and Vanguard Group Inc (2.00%). Company insiders that own Cardlytics stock include David Thomas Evans, Kirk Somers, Lynne Marie Laube, Polaris Venture Management Co and Scott D Grimes. View Institutional Ownership Trends for Cardlytics.
Which institutional investors are selling Cardlytics stock?
CDLX stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co. and Jennison Associates LLC. Company insiders that have sold Cardlytics company stock in the last year include David Thomas Evans, Kirk Somers, Lynne Marie Laube, Polaris Venture Management Co and Scott D Grimes. View Insider Buying and Selling for Cardlytics.
Which institutional investors are buying Cardlytics stock?
CDLX stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Frontier Capital Management Co. LLC, Allianz Asset Management GmbH, Emerald Mutual Fund Advisers Trust, Vanguard Group Inc, Vanguard Group Inc., North Fourth Asset Management LP and BlackRock Inc.. Company insiders that have bought Cardlytics stock in the last two years include David Thomas Evans and Scott D Grimes. View Insider Buying and Selling for Cardlytics.
How do I buy shares of Cardlytics?
Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cardlytics' stock price today?
One share of CDLX stock can currently be purchased for approximately $12.92.
How big of a company is Cardlytics?
Cardlytics has a market capitalization of $274.17 million and generates $130.37 million in revenue each year. The company earns $-19,640,000.00 in net income (profit) each year or ($8.02) on an earnings per share basis. Cardlytics employs 342 workers across the globe.
What is Cardlytics' official website?
How can I contact Cardlytics?
Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]
MarketBeat Community Rating for Cardlytics (NASDAQ CDLX)
MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote "Outperform" if you believe CDLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDLX will underperform the S&P 500 over the long term. You may vote once every thirty days.
